BCL2 and hepatocellular carcinoma: Among the molecular mechanisms responsible for sorafenib effectivity in HCC cells is the activation of programmed cell death, apoptosis, provoked by the downregulation of myeloid cell leukemia sequence 1 (MCL-1) expression, an anti-apoptotic member of the BCL-2 family [148].